Gestipharma SA
1.3 FTEThe score of Gestipharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +5 % Total assets +9 % Headcount (avg FTE) +30 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Gestipharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 77,529 € | ||||
| Equity | 815,663 € | ||||
| Cash | 409,067 € | ||||
| EBITDA | 154,247 € | ||||
| Total assets | 859,421 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 06 Aug 2024
- Year ended 31 Dec 2022filed on 23 Aug 2023
- Year ended 31 Dec 2021filed on 16 Aug 2022
Gestipharma's financial analysis
- Solvency94.9%sector median: 50.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Gestipharma
Gestipharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0425.530.684
- VAT number
- BE0425530684
- Peppol
- Registered · 0208:0425530684 · as of 06 Nov 2026
- Legal form
- SA
- Incorporated
- 31 Dec 1983
- Registered office
- 7022 Mons
- Size
- Micro · 1.3 FTE
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Gestipharma (SA) has been based in Mons since 1983, active in: business and other management consultancy activities. For 2025, it reports a net profit of 77,529 € and equity of 815,663 €; its revenue is not published. With 1.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 94.9%, above the median of its sector (50.1%).
Companies similar to Gestipharma
Companies in the same business, of comparable size and area, outside its group.
- GeMo&do Business and other management consultancy activities Mol · balance sheet 859,557 €
- Waterloo Construct Consulting Business and other management consultancy activities Rixensart · balance sheet 859,692 €
- Heca Consult Business and other management consultancy activities Aartselaar · balance sheet 858,764 €
- Pass & Partners Business and other management consultancy activities Tremelo · balance sheet 858,626 €
- Hesima Business and other management consultancy activities Herent · balance sheet 860,223 €
- Koen Vandevenne Business and other management consultancy activities Genk · balance sheet 860,385 €
- JPRoisin Business and other management consultancy activities Woluwe-Saint-Pierre · balance sheet 860,520 €
- Berckmoes-Joos Consulting Business and other management consultancy activities Hamme (Vl.) · balance sheet 860,575 €
Frequently asked questions about Gestipharma
What is the revenue of Gestipharma?
Gestipharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Gestipharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0425530684 for Gestipharma, if the company is VAT-registered. Its company number (CBE) is 0425.530.684.
Where is the registered office of Gestipharma?
According to the CBE register, the registered office of Gestipharma is in 7022 Mons.
What is the equity of Gestipharma?
At the close of the 2025 financial year, the equity of Gestipharma amounts to 815,663 €, a solvency of 94.9% of total assets.
How many people work at Gestipharma?
1.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Gestipharma?
The register lists 3 active mandates at Gestipharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Gestipharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →